4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0001209191-22-057397
EVP - Business Operations acquired 1,524,947 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Masson Kristina EVP - Business Operations | 2022-11-14 | Grant or award | +26,707 | 320,705 | D | ||
| Masson Kristina EVP - Business Operations | 2022-11-14 | Grant or award | +934,731 | 1,806,588 | I | ||
| Masson Kristina EVP - Business Operations | 2022-11-14 | Grant or award | +503,419 | 2,310,007 | I | ||
| Masson Kristina EVP - Business Operations | 2022-11-14 | Grant or award | +60,090 | 2,370,097 | I | ||
| Derivatives | |||||||
| Masson Kristina EVP - Business Operations | 2022-11-14 | Grant or award · Stock Option (Right to Buy) | +80,120 | 80,120 | D | ||
| Masson Kristina EVP - Business Operations | 2022-11-14 | Grant or award · Stock Option (Right to Buy) | +180,269 | 180,269 | I | ||
Loading xslF345X03/doc4.xml…